BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 24064836)

  • 1. [JSH guideline for multiple myeloma].
    Hata H
    Rinsho Ketsueki; 2013 Oct; 54(10):1850-5. PubMed ID: 24064836
    [No Abstract]   [Full Text] [Related]  

  • 2. [Guidelines for the diagnosis and management of multiple myeloma by the Japan Myeloma Study Group].
    Shimizu K;
    Rinsho Ketsueki; 2005 Jun; 46(6):424-32. PubMed ID: 16447724
    [No Abstract]   [Full Text] [Related]  

  • 3. [The outline of myeloma management guidelines by Japan Myeloma Study Group].
    Nagura E
    Nihon Rinsho; 2007 Jan; 65 Suppl 1():350-5. PubMed ID: 17474431
    [No Abstract]   [Full Text] [Related]  

  • 4. Progress in treating multiple myeloma. Thanks to a host of effective new therapies, patients are enjoying years in remission from this malignant blood cancer.
    Harv Womens Health Watch; 2010 Jul; 17(11):4-6. PubMed ID: 20684078
    [No Abstract]   [Full Text] [Related]  

  • 5. JSH practical guidelines for hematological malignancies, 2018: III. Myeloma-1. Multiple myeloma (MM).
    Iida S; Ishida T; Murakami H; Ozaki S; Abe M; Hata H; Shimazaki C
    Int J Hematol; 2019 May; 109(5):509-538. PubMed ID: 30949913
    [No Abstract]   [Full Text] [Related]  

  • 6. Updates to the guidelines for the diagnosis and management of multiple myeloma.
    Pratt G; Jenner M; Owen R; Snowden JA; Ashcroft J; Yong K; Feyler S; Morgan G; Cavenagh J; Cook G; Low E; Stern S; Behrens J; Davies F; Bird J
    Br J Haematol; 2014 Oct; 167(1):131-3. PubMed ID: 24801672
    [No Abstract]   [Full Text] [Related]  

  • 7. Myeloma and leukaemia trials.
    Peto R
    Proc R Soc Med; 1972 Mar; 65(3):244-5. PubMed ID: 4563299
    [No Abstract]   [Full Text] [Related]  

  • 8. [Interleukin-6 reflects the disease severity and prognosis of myeloma].
    Pelliniemi TT; Pulkki K
    Duodecim; 1996; 112(7):563-5. PubMed ID: 10592621
    [No Abstract]   [Full Text] [Related]  

  • 9. Therapeutic strategies in multiple myeloma.
    Durie BG; Salmon S
    Bull Cancer; 1980; 67(4):450-7. PubMed ID: 7225602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Introduction: recent advances in the understanding and management of multiple myeloma.
    Jakubowiak AJ
    Semin Oncol; 2013 Oct; 40(5):535-6. PubMed ID: 24135397
    [No Abstract]   [Full Text] [Related]  

  • 11. Multiple myeloma: how far have we come?
    Anderson KC
    Mayo Clin Proc; 2003 Jan; 78(1):15-7. PubMed ID: 12528872
    [No Abstract]   [Full Text] [Related]  

  • 12. "Should all eligible patients with multiple myeloma receive autologous stem-cell transplant as part of initial treatment?".
    Moreau P; Rajkumar SV
    Leuk Res; 2012 Jun; 36(6):677-81. PubMed ID: 22430045
    [No Abstract]   [Full Text] [Related]  

  • 13. [The CBO professional guideline 'monoclonal gammopathy' (paraproteinemia) (revision)].
    Buiting AM; Wijermans PW
    Ned Tijdschr Geneeskd; 2002 Jul; 146(30):1406-11. PubMed ID: 12174434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of multiple myeloma.
    Brodsky I; Kahn SB; Meyer AN
    Geriatrics; 1967 Mar; 22(3):140-8. PubMed ID: 6019488
    [No Abstract]   [Full Text] [Related]  

  • 15. [Prognosis of multiple myeloma].
    Morell A; Skvaril F; Rüst HP; Spengler GA; Brunner K; Barandun S
    Schweiz Med Wochenschr; 1970 Nov; 100(46):1990-2. PubMed ID: 5507847
    [No Abstract]   [Full Text] [Related]  

  • 16. [Multiple myeloma and idiopathic monoclonal gammapathy. Diagnosis, prognosis and treatment].
    Bladé J
    Med Clin (Barc); 1988 Apr; 90(17):704-14. PubMed ID: 3045448
    [No Abstract]   [Full Text] [Related]  

  • 17. Guidelines for the diagnosis and management of multiple myeloma 2011.
    Bird JM; Owen RG; D'Sa S; Snowden JA; Pratt G; Ashcroft J; Yong K; Cook G; Feyler S; Davies F; Morgan G; Cavenagh J; Low E; Behrens J;
    Br J Haematol; 2011 Jul; 154(1):32-75. PubMed ID: 21569004
    [No Abstract]   [Full Text] [Related]  

  • 18. Prediction of therapeutic response in multiple myeloma by means of bone marrow cytologic examination.
    Rapazzini P; Bettini R; Carcano L
    Haematologica; 1984; 69(6):768-9. PubMed ID: 6441756
    [No Abstract]   [Full Text] [Related]  

  • 19. [Prognositic factors in multiple myeloma].
    Nagura E
    Nihon Rinsho; 2007 Dec; 65(12):2351-6. PubMed ID: 18069282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple myeloma: a therapeutic enigma.
    Hoogstraten B
    Am J Clin Oncol; 1982 Feb; 5(1):13-9. PubMed ID: 7081135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.